We know now more than ever with the COVID-19 crisis that the essential services we provide our customers have never been more critical. Toxikon is working diligently to continue to serve as your single-source provider for preclinical safety and efficacy testing to ensure your healthcare products can reach patients.
We remain committed to supporting the life science industry during the COVID-19 pandemic and have continued to take steps necessary to continue operations with minimal disruptions.
Toxikon has launched its own COVID-19 Task Force to protect our employees, customers, and suppliers. Our processes of protection and flexibility allow us to continue operating and provide data as quickly as possible to published turnaround times. However, we do ask for your ongoing patience as we take necessary precautions to carry out studies as efficiently as possible while maintaining social distancing and flexible work schedules.
Please continue to contact your Sales and/or Customer Service representatives or Study Directors as needed for follow-up information or questions.
The health and safety of our employees and sponsors is our top priority, and we will keep you updated with any new developments as this situation continues to evolve. We are in uncertain times, but working at a “distance” helps us to continue working together safely as one team.
We wish you continued good health.
Thank you for your trust and your business.
Laxman S. Desai, D.Sc.
President & CEO, Toxikon